advisorsecurities master

ABSIAbsci Corporation Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
11201
Ticker
ABSI
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2021-07-22
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
ABSI

Detail

Enriched 2026-08-14 20:47

Market cap
$1,630,333,095
Shares outstanding (class)
155,905,056
Shares outstanding (weighted)
171,614,010
SIC
8731 SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Employees
140
Location
VANCOUVER, WA
Description

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data